GLYCOEXPRESS - Trademark Details
Status: 709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Serial Number
79068784
Registration Number
3991708
Word Mark
GLYCOEXPRESS
Status
709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Status Date
2022-01-28
Filing Date
2008-11-27
Registration Number
3991708
Registration Date
2011-07-12
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2011-04-26
Attorney Name
Law Office Assigned Location Code
M70
Employee Name
LEE, DEBRA ANN
Statements
Goods and Services
[Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilizing preparations; fire extinguishing compositions; tempering and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elements, fragments, fractions and lysates thereof, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment, bacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cells, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment; biological preparations for laboratories, except for medical or veterinary purposes, namely, for use in bacterial and cell engineering, cultivation, harvesting, protein production; chemical preparations for analysis in laboratories, namely, preparations for protein, peptide, engineered proteins and peptides, glycoproteins, glycosylation, antibody or antigen analysis, preparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein production, bacterial and cell engineering, cultivation and harvesting, probes for detecting and analyzing molecules in protein or nucleotide arrays, except for medical or veterinary purposes; diagnostic preparations, except for medical or veterinary purposes; enzymes, proteins and respective preparations for industrial purposes, namely, engineered proteins, glycosylated proteins, antibodies, enzymes for use in glycosylation, enzyme substrates, proteins used in the manufacture of cosmetics, beverages, food products and food supplements; ferments for chemical purposes, namely, yeast, bacterium, mold, or enzyme, that causes fermentation; in-vitro diagnostic preparations, other than for medical purposes; carbohydrates used as an ingredient or as an integral component in food or nutraceuticals; cultures of microorganisms and cells and elements, fragments, fractions and lysates thereof, other than for medical or veterinary purposes, namely, cultures of microorganisms and cells other than for medical and veterinary use, microorganism or cell cultures for use in protein production, food manufacturing, scientific research, waste water treatment, cultures of microorganisms or cells for use in expression of glycosylated proteins and peptides; gene expression systems for proteins and peptides, particularly on the basis of cells, particularly human cells and microorganisms, namely, gene expression systems comprising biochemicals, assays, and reagents for use in manufacturing engineered or glycosylated proteins or peptides and for scientific research, gene expression systems comprising biochemicals, assays and reagents with optimized glycosylation activity for use in manufacturing proteins or peptides, in particular engineered or glycosylated proteins or peptides, and for scientific research; milk ferments for medical research purposes]
Goods and Services
[Pharmaceutical and veterinary preparations for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; medical plasters; materials for medical dressings; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicides; adjuvants for medical purposes; medicines for human and veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzyme, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine, and as nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; carbohydrates for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of human cells for medical or veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; medical drinks for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; microorganisms, cells and preparations containing elements, fragments, fractions and lysates of microorganisms or cells for medical and veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological therapeutics, namely, therapeutics containing cells, microorganisms, proteins, glycoproteins, peptides, glycopeptides or modified or conjugated versions thereof for use in the prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; milk ferments for pharmaceutical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposes for human or animals, namely, nutritional additives in the nature of enzymes, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof; sugar and carbohydrates for medical purposes, namely, therapeutically and prophylactically active sugar and carbohydrates, dietetic sugar and carbohydrates, sugar and carbohydrate replacements]
Goods and Services
Scientific and technological services, namely, [bacteria and] cell engineering services, [bacteria and] cell cultivation and harvesting services, research and development related to protein production, glycosylation, optimization of protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; research and design services in the field of biotechnology, protein production, glycosylation, optimization of protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; industrial analysis and research services in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; [design and development of computer hardware and software;] biological research; services of a [chemical or] biological laboratory; [technical surveys, namely, conducting biotechnology surveys, pharmacology surveys; conducting scientific surveys in the field of biotechnology, bacterial and cell engineering, protein production, glycosylation;] research and development in the field of [bacteriology, ]cytology, antibody technology, [chemistry, immunology, cosmetics of expression systems in the nature of glycosylation of proteins, peptides, antibodies and enzymes, particularly for proteins and peptides; quality control;] research and development of new products and technologies in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity,[ bacteria and] cell engineering, cultivation and harvesting for others; technology and scientific consultancy in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; research and development in the field of glycomics, expression systems in the nature of glycosylation of proteins, peptides, antibodies and enzymes, development and improvement of cells, cell lines [and microorganisms,] antibody-engineering, optimized biological therapeutics; [nutraceuticals, and food and nutritional supplements;] research, [quality control,] technology consultancy and product development in the field of proteins, antibodies, [microorganisms] and cells; research and development in the field of [microorganisms and] cells
Pseudo Mark
GLYCOTOPE EXPRESS; GLYCOMICS EXPRESS
Pseudo Mark
GLYCOTOPE EXPRESS; GLYCOMICS EXPRESS
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
G - Sec. 71 - Class(es) in a Multiple Class Registration
Class Status Date
2017-07-27
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
G - Sec. 71 - Class(es) in a Multiple Class Registration
Class Status Date
2017-07-27
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2022-01-28
Primary Code
042
Correspondences
Name
GARY D. KRUGMAN
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1002620
International Registration Date
2008-11-27
International Publication Date
2009-06-25
International Renewal Date
2028-11-27
Auto Protection Date
2011-03-17
International Status
001 - Request for extension of protection established
International Status Date
2009-06-18
Priority Claimed In
True
Priority Claimed Date
2008-05-28
First Refusal In
True
Trademark Events
Event Date | Event Description |
2009-06-18 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2009-06-19 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2009-06-19 | ASSIGNED TO EXAMINER |
2009-06-23 | APPLICATION FILING RECEIPT MAILED |
2009-06-25 | NON-FINAL ACTION WRITTEN |
2009-06-26 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2009-06-26 | REFUSAL PROCESSED BY MPU |
2009-06-26 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2009-09-18 | CORRECTION TRANSACTION RECEIVED FROM IB |
2009-09-19 | REFUSAL PROCESSED BY IB |
2009-09-25 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
2009-10-17 | ATTORNEY REVIEW COMPLETED |
2009-11-30 | LIMITATION OF GOODS RECEIVED FROM IB |
2009-12-22 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2010-01-05 | LIMITATION OF GOODS/SERVICES FROM IB ENTERED |
2010-01-21 | LIMITATION OF GOODS RECEIVED FROM IB |
2010-01-21 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
2009-12-22 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2010-07-27 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2010-08-11 | FINAL REFUSAL WRITTEN |
2010-08-12 | FINAL REFUSAL MAILED |
2010-10-28 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2010-10-28 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2011-01-31 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2011-01-31 | ASSIGNED TO LIE |
2011-02-02 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2011-02-02 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2011-02-14 | EXPARTE APPEAL RECEIVED AT TTAB |
2011-02-14 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
2011-02-14 | EX PARTE APPEAL-INSTITUTED |
2011-02-17 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
2011-02-17 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2011-03-05 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
2011-03-11 | ACTION CONTINUING FINAL - COMPLETED |
2011-03-11 | ACTION DENYING REQ FOR RECON E-MAILED |
2011-03-11 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED |
2011-03-21 | EXAMINERS AMENDMENT -WRITTEN |
2011-03-21 | EXAMINERS AMENDMENT E-MAILED |
2011-03-21 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2011-03-21 | EXAMINER'S AMENDMENT ENTERED |
2011-03-21 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2011-03-22 | EXPARTE APPEAL TERMINATED |
2011-03-22 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2011-04-06 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2011-04-06 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2011-04-23 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
2011-04-26 | PUBLISHED FOR OPPOSITION |
2011-04-26 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2011-07-12 | REGISTERED-PRINCIPAL REGISTER |
2011-10-12 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2012-01-05 | FINAL DISPOSITION PROCESSED |
2012-01-06 | FINAL DISPOSITION NOTICE SENT TO IB |
2013-03-03 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2013-12-14 | NEW REPRESENTATIVE AT IB RECEIVED |
2017-07-06 | TEAS SECTION 71 & 15 RECEIVED |
2017-07-22 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2017-07-27 | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. |
2017-07-27 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
2018-09-03 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
2018-09-13 | INVALIDATION PROCESSED |
2018-09-13 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
2018-10-19 | PARTIAL INVALIDATION PROCESSED BY THE IB |
2018-12-27 | INTERNATIONAL REGISTRATION RENEWED |
2019-12-16 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2019-12-16 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2020-07-12 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
2022-01-28 | CANCELLED SECTION 71 |